XNK Therapeutics presented two posters at the NK2023 conference in Oslo
XNK Therapeutics AB today announced that two posters, regarding bladder cancer (BC) and acute myeloid leukemia (AML) respectively, was presented at the 20[th] Meeting of the Society for Natural Immunity (NK2023) in Oslo, Norway, in September.